Comparing cancer therapy in the United States and Europe reveals notable differences in philosophy. The US system, often characterized as fee-for-service , tends to emphasize cutting-edge innovations , frequently resulting in greater costs and inconsistent access to care. Conversely, many European systems operate under universal healthcare models,